118 results in Exploration of Drug Science
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Short Communication
FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
Muhammad Mazhar Azam ... Bibek Giri
Published: December 03, 2024 Explor Drug Sci. 2024;2:867–874
9823 95 4
Open Access Review
FDA-approved kinase inhibitors: a promising therapeutic avenue for traumatic brain injury
Dezhu Gao ... Weiming Liu
Published: December 2, 2024 Explor Drug Sci. 2024;2:851–866
1676 28 0
Open Access Review
Technetium-99m-labeled peptides and their applications in radio imaging: advancements in Latin American research
Vaezeh Fathi Vavsari, Saeed Balalaie
Published: November 20, 2024 Explor Drug Sci. 2024;2:814–835
1549 33 0
Open Access Review
Bio-mimetic strategies to re-activate apoptotic cell death for cancer treatments
Andrea Venerando ... Rossella De Marco
Published: November 11, 2024 Explor Drug Sci. 2024;2:785–813
1604 21 0
Open Access Review
Unlocking nature’s pharmacy: an in-depth exploration of phytochemicals as potential sources of anti-cancer and anti-inflammatory molecules
Shifana C. Sadiq ... Ruby John Anto
Published: October 30, 2024 Explor Drug Sci. 2024;2:744–784
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
3032 76 0
Open Access Mini Review
Lactoferrin: a secret weapon in the war against pathogenic bacteria
Lucero Ruiz-Mazón ... Mireya de la Garza
Published: October 21, 2024 Explor Drug Sci. 2024;2:734–743
3728 74 0
Open Access Original Article
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
Qian Wang ... Shiyu Chen
Published: October 17, 2024 Explor Drug Sci. 2024;2:719–733
This article belongs to the special issue Bioactive Peptides discovery and development
1750 47 1
Open Access Review
Synthetic peptides as valuable and versatile tools for research: our 20 year journey in Chile
Constanza Cárdenas ... Fanny Guzmán
Published: October 15, 2024 Explor Drug Sci. 2024;2:701–718
2452 68 1
Open Access Perspective
Foundational contributions of Svetlana Mojsov to the GLP-1 field
George Barany, Michael J. Barany
Published: October 3, 2024 Explor Drug Sci. 2024;2:688–700
3371 62 0
Open Access Original Article
Prediction of absolute bioavailability of medicines in children: based on predicted pediatric clearance from adults
Iftekhar Mahmood
Published: September 30, 2024 Explor Drug Sci. 2024;2:677–687
1128 19 0
Open Access Review
Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
Yethindra Vityala ... Krishna Chaitanya Meduri
Published: September 30, 2024 Explor Drug Sci. 2024;2:666–676
2663 19 0
Open Access Review
21st century Latin American synthetic peptides for their application in antivenom production
Jésica A. Rodríguez ... Silvia A. Camperi
Published: September 30, 2024 Explor Drug Sci. 2024;2:648–665
1619 37 0
Open Access Original Article
Properties of new polycationic bacteriochlorin photosensitizers: cytotoxicity and interaction with biofilms
Irina Tiganova ... Yulia Romanova
Published: September 27, 2024 Explor Drug Sci. 2024;2:632–647
This article belongs to the special issue Discovery and development of new antibacterial compounds
1365 29 0
Open Access Original Article
Hybrid peptides inspired by the RWQWRWQWR sequence inhibit cervical cancer cells growth in vitro
Natalia Ardila-Chantré ... Javier Eduardo García-Castañeda
Published: September 27, 2024 Explor Drug Sci. 2024;2:614–631
1717 40 2
Open Access Review
Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
Tanya Tripathi ... Alok Chandra Bharti
Published: September 24, 2024 Explor Drug Sci. 2024;2:583–613
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
1644 41 0
Open Access Review
Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
Sasikumar Jalajakumari Soumya ... Perumana R. Sudhakaran
Published: September 13, 2024 Explor Drug Sci. 2024;2:567–582
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
2246 49 1
Open Access Review
Chemo-selective modification of cysteine residue: synthesis and application in the discovery of potential drug candidates
Yanyan Liao, Xuefeng Jiang
Published: September 06, 2024 Explor Drug Sci. 2024;2:540–554
This article belongs to the special issue Bioactive Peptides discovery and development
2553 93 2
Open Access Review
A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules
Tejaswini Masne ... Deepali Bansode
Published: September 06, 2024 Explor Drug Sci. 2024;2:508–539
3109 115 3